Silence Therapeutics plc (SLN) SEC Filings & Financial Intelligence
Silence Therapeutics plc (SLN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SLN
CIK: 1479615
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerDavid Farmer
Audit LocationReading, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-006906 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0000919574-26-006888 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-096202 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0002005369-26-000047 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-10 | OWNERSHIP DOCUMENT | 0001104659-26-095574 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-10 | 8-K | 0001193125-26-347196 | View SEC Doc Filr Page |
| 424B5 | 2026-08-12 | — | 424B5 | 0001193125-26-347191 | View SEC Doc Filr Page |
| S-3MEF | 2026-08-11 | — | S-3MEF | 0001193125-26-345465 | View SEC Doc Filr Page |
| 424B5 | 2026-08-10 | — | 424B5 | 0001193125-26-342633 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341293 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-341248 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341240 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-16 | 2026-07-10 | 8-K/A | 0001193125-26-306251 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-08 | — | SCHEDULE 13D/A Filing | 0001104659-26-081559 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-06-29 | OWNERSHIP DOCUMENT | 0001104659-26-080997 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001193125-26-279577 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | 8-K | 0001193125-26-272814 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001193125-26-266705 | View SEC Doc Filr Page |
| EFFECT | 2026-05-27 | — | EFFECT Filing | 9999999995-26-001774 | View SEC Doc Filr Page |
| 424B5 | 2026-05-27 | — | 424B5 | 0001193125-26-242060 | View SEC Doc Filr Page |
| CORRESP | 2026-05-22 | — | CORRESP Filing | 0001193125-26-236865 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-22 | — | UPLOAD Filing | 0000000000-26-005242 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001193125-26-229089 | View SEC Doc Filr Page |
| S-3 | 2026-05-18 | — | S-3 | 0001193125-26-228915 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-210446 | View SEC Doc Filr Page |